
Alumis Inc
ALMSHealthcare|Biotechnology|USA
$28.32
-1.96 (-6.48%)
Tangible Book
$4.06
Analyst Estimates
annual
{
"date": [
"202612",
"202712",
"202812",
"202912",
"203012"
],
"revenue_estimate": [
8.44,
23.48,
164.88,
430.72,
920.83
],
"ebit_estimate": [
-382.53,
-390.81,
-288.77,
-123.42,
394.18
],
"ebitda_estimate": [
-377.03,
-343.19,
-136.97,
null,
null
],
"net_income_estimate": [
-371.27,
-377.46,
-277.75,
-107.62,
417.95
],
"per_share_eps_estimate": [
-2.83,
-2.62,
-1.88,
-0.64,
1.62
],
"eps_nri_estimate": [
-2.85,
-2.63,
-1.74,
-0.64,
1.62
],
"dividend_estimate": [
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
1.18,
0.39,
0.78,
null,
null
],
"pretax_income_estimate": [
-371.24,
-382.75,
-277.75,
-107.65,
417.95
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null
],
"roe_estimate": [
-127.19,
-174.56,
-87.92,
null,
null
],
"gross_margin_estimate": [
null,
null,
90,
90,
90
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
17.5
],
"long_term_growth_rate_mean": 14.6,
"long_term_revenue_growth_rate_mean": "97.37",
"future_per_share_eps_estimate_growth": 12.52,
"future_eps_nri_estimate_growth": 14.6,
"future_revenue_estimate_growth": 97.37,
"future_ebit_estimate_growth": 12.49,
"future_ebitda_estimate_growth": 30.68,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": -39.49,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}
quarterly
{
"date": [
"202606",
"202609",
"202612",
"202703",
"202706",
"202709",
"202712"
],
"revenue_estimate": [
4.02,
1.78,
1.78,
0.6,
0.6,
4.6,
11.78
],
"ebit_estimate": [
-93.01,
-95.37,
-96.73,
-97.2,
-98.68,
-96.57,
-91.59
],
"ebitda_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"net_income_estimate": [
-90.3,
-92.52,
-94.07,
-92.89,
-93.49,
-90.41,
-85.22
],
"per_share_eps_estimate": [
-0.72,
-0.7,
-0.69,
-0.66,
-0.66,
-0.64,
-0.59
],
"eps_nri_estimate": [
-0.73,
-0.7,
-0.69,
-0.66,
-0.66,
-0.64,
-0.59
],
"dividend_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"book_value_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pretax_income_estimate": [
-90.3,
-92.52,
-94.19,
-93.85,
-95.41,
-93.38,
-88.88
],
"operating_cash_flow_per_share_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roa_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"roe_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"gross_margin_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"operating_cash_flow_estimate": [
null,
null,
null,
null,
null,
null,
null
],
"pettm_estimate": [
0,
0,
0,
0,
null,
null,
null
],
"long_term_growth_rate_mean": 14.6,
"long_term_revenue_growth_rate_mean": "97.37",
"future_per_share_eps_estimate_growth": 12.52,
"future_eps_nri_estimate_growth": 14.6,
"future_revenue_estimate_growth": 97.37,
"future_ebit_estimate_growth": 12.49,
"future_ebitda_estimate_growth": 30.68,
"future_dividend_estimate_growth": null,
"future_net_income_estimate_growth": null,
"future_pretax_income_estimate_growth": null,
"future_book_value_per_share_estimate_growth": -39.49,
"future_roa_estimate_growth": null,
"future_roe_estimate_growth": null,
"future_gross_margin_estimate_growth": null,
"future_operating_cash_flow_per_share_estimate_growth": null
}